T*C
发帖数: 5492 | 1 Human Genome Sciences (HGSI). The drug developer, which agreed to be bought
by GlaxoSmithKline (GSK) earlier this month for $14.25 per share, says it
received and rejected a much higher $35 per share takeover bid by Amgen (
AMGN) back in August, 2010. It decided not to sell at the time because
regulatory approval for its lupus drug Benlystsa was expected later that
year.
这个就像Groupon拒绝了google的offer，$6b，groupon现在的市值才4.27B，而且还在
跌，明天估计要跌破4b | b**a
发帖数: 1118 | 2 Anyone knows what is happening to HGSI? Now the expire date (July 27, 2012)
of GKS's offer already past, why is it still trading at 14.25? What will
happen later for those who did not sell their shares?
Thanks.
bought
【在 T*C 的大作中提到】
: Human Genome Sciences (HGSI). The drug developer, which agreed to be bought
: by GlaxoSmithKline (GSK) earlier this month for $14.25 per share, says it
: received and rejected a much higher $35 per share takeover bid by Amgen (
: AMGN) back in August, 2010. It decided not to sell at the time because
: regulatory approval for its lupus drug Benlystsa was expected later that
: year.
: 这个就像Groupon拒绝了google的offer，$6b，groupon现在的市值才4.27B，而且还在
: 跌，明天估计要跌破4b
| Q*Q
发帖数: 869 | | b**a
发帖数: 1118 | 4 Anyone knows? I have some shares but not sure what if I do not sell them now.
)
【在 b**a 的大作中提到】
: Anyone knows what is happening to HGSI? Now the expire date (July 27, 2012)
: of GKS's offer already past, why is it still trading at 14.25? What will
: happen later for those who did not sell their shares?
: Thanks.
:
: bought
|
|
